Levosimendan: Clinical Trials

22 trials of Levosimendan, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

14 completed, 6 unknown, 1 not yet recruiting, 1 terminated. 22 Phase 2, 6 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 222Completed 14, Unknown 6, Not yet recruiting 1, Terminated 1
Phase 36Unknown 4, Completed 1, Not yet recruiting 1
Phase 11Completed 1

Follow Levosimendan: new trials by email Literature Review of Levosimendan trials Research Report on Levosimendan

Trials (filtered) newest first · largest first

All 22 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Levosimendan in Acute Decompensated Heart Failure
Levosimendan, Standard care - Acute Decompensated Heart Failure (ADHF)
Phase 2 / Phase 3Not yet recruitingChittagong Medical College3322025-12-012025-12-04
Levosimendan as Treatment of Aneurysmal SubArachnoid Haemorrhage
Levosimendan, Placebo - Sub-arachnoid Haemorrhage
Phase 2CompletedAssistance Publique - Hôpitaux de Paris302023-10-132026-08-31
Using TEE to Evaluate the Effect of Levosimendan on Patients With ARDS Associated With RVD During MV
levosimendan, 5% glucose injection - Transesophageal Echocardiography, Acute Respiratory Distress Syndrome
Phase 2 / Phase 3UnknownUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology582023-03-222023-03-14
Levosimendan in Patients With Impaired Right Ventricular Function Undergoing Cardiac Surgery
Levosimendan, Standard Care - Right Heart Failure, Open-heart Surgery
Phase 2UnknownAin Shams University402021-08-182021-10-20
Spanish Randomized Clinical Trial to Compare Levosimendan Versus Placebo in Postoperative Cardiac Surgery (SPARTANS)
Levosimendan, Placebos - Cardiac Output, Low
Phase 2 / Phase 3UnknownMaría de los Ángeles Tena Pajuelo3002020-06-172020-07-24
Open-Label Rollover Study of Levosimendan in PH-HFpEF Patients
Levosimendan - Hypertension Pulmonary Secondary Heart Failure, Right Sided Heart Failure With Normal Ejection Fraction
Phase 2CompletedTenax Therapeutics, Inc.352019-04-092026-04-22
Hemodynamic Evaluation of Levosimendan in Patients With PH-HFpEF
Levosimendan, Matching Placebo - Hypertension Pulmonary Secondary, Heart Failure, Right Sided
Phase 2CompletedTenax Therapeutics, Inc.442018-11-142024-11-20
Levosimendan for Cardiac Patients Undergoing Major Abdominal Cancer Surgeries
Levosimendan, Saline - Heart Failure
Phase 2CompletedNational Cancer Institute, Egypt602017-08-012018-06-14
Levosimendan in Acute Kidney Injury Study
Levosimendan, Conventional therapy - Acute Kidney Injury
Phase 2 / Phase 3CompletedVieCuri Medical Centre682016-09-012026-08-21
Effects of ODM-109 on Respiratory Function in Patients With Amyotrophic Lateral Sclerosis
ODM-109, Placebo for ODM-109 - Amyotrophic Lateral Sclerosis
Phase 2CompletedOrion Corporation, Orion Pharma662015-07-012017-11-28
Is Levosimendan Superior to Milrinone Regarding Acute Kidney Injury After Cardiac Surgery for Congenital Heart Disease?
Levosimendan, Milrinone - Congenital Heart Defects
Phase 2CompletedGöteborg University722014-10-152024-03-26
Effects of Levosimendan on Diaphragm Function in Mechanically Ventilated Patients
Levosimendan, Placebo - Muscle Weakness Conditions, Weaning Failure
Phase 2 / Phase 3UnknownUniversity Medical Center Nijmegen422012-09-012015-06-10
Efficacy and Safety of Levosimendan in Severe Acute Heart Failure in Critical Children
Levosimendan, Conventional intensified inotropic treatment - Acute Heart Failure
Phase 2TerminatedJose Luis Vazquez Martinez1162011-02-012013-01-31
Two Inodilators Postsurgery in Neonates
Milrinone, Levosimendan - Low Cardiac Output Syndrome
Phase 1 / Phase 2CompletedFundacion para la Investigacion Biomedica del Hospital Universitario la Paz202009-11-012012-04-12
Levosimendan Administration in Neonates With Transposition of the Great Arteries
levosimendan, placebo - Low Cardiac Output Syndrome
Phase 2CompletedBambino Gesù Hospital and Research Institute632009-01-012012-06-26
Effects of Oral Levosimendan on Ambulatory Electrocardiographic Variables
Levosimendan, Placebo - Transient Ischemic Attack, Stroke
Phase 2CompletedOrion Corporation, Orion Pharma322008-08-012009-11-25
Effects of Levosimendan on Microcirculation in Septic Shock
Levosimendan, dobutamine - Septic Shock
Phase 2CompletedUniversity of Roma La Sapienza402007-11-012009-10-15
Prophylactic Use of Levosimendan Versus Milrinone in Open Heart Surgery in Infants
Levosimendan, Milrinone - Low Cardiac Output Syndrome
Phase 2UnknownLudwig Boltzmann Gesellschaft402007-09-012007-10-25
Myocardial Hemodynamic Effects of Levosimendan
levosimendan - Heart Failure
Phase 2CompletedUniversity of Utah102006-09-012013-05-21
Peroral Levosimendan in Chronic Heart Failure
levosimendan - Chronic Heart Failure, Heart Diseases
Phase 2CompletedOrion Corporation, Orion Pharma3002005-03-012007-02-21

Showing 20 of 22. Sign in to see all of them.

Conditions studied

Heart Failure (5)  ·  Cardiac Output, Low (4)  ·  Heart Defects, Congenital (2)  ·  Sepsis (2)  ·  Shock, Septic (2)  ·  Stroke (2)  ·  Acute Kidney Injury (1)  ·  Amyotrophic Lateral Sclerosis (1)  ·  Coronary Disease (1)  ·  Heart Diseases (1)  ·  Ischemic Attack, Transient (1)  ·  Respiratory Distress Syndrome (1)  ·  Shock (1)  ·  Shock, Cardiogenic (1)  ·  Transposition of Great Vessels (1)

Sponsors

Orion Corporation, Orion Pharma (4)  ·  Tenax Therapeutics, Inc. (2)  ·  Ain Shams University (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Bambino Gesù Hospital and Research Institute (1)  ·  Chittagong Medical College (1)  ·  Fundacion para la Investigacion Biomedica del Hospital Universitario la Paz (1)  ·  Göteborg University (1)  ·  Jose Luis Vazquez Martinez (1)  ·  Ludwig Boltzmann Gesellschaft (1)  ·  María de los Ángeles Tena Pajuelo (1)  ·  National Cancer Institute, Egypt (1)  ·  Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1)  ·  University Medical Center Nijmegen (1)  ·  University of Roma La Sapienza (1)

Countries

Finland (4)  ·  Netherlands (3)  ·  Spain (3)  ·  United States (3)  ·  Egypt (2)  ·  Germany (2)  ·  Italy (2)  ·  Sweden (2)  ·  Australia (1)  ·  Austria (1)  ·  Bangladesh (1)  ·  China (1)  ·  France (1)  ·  Hungary (1)  ·  Ireland (1)

Top investigators

Adelina Pellicer, PhD (1)  ·  Albert Castellheim, MD, PhD (1)  ·  Andrea Morelli, M.D. (1)  ·  Andrew Michaels, MD (1)  ·  Anna Hofer, MD (1)  ·  Benjamin Glen Chousterman (1)  ·  Birgitta Romlin, MD, PhD (1)  ·  Carlos Labrandero, MD (1)  ·  Ehab H Shaker, MD (1)  ·  Elin Thorlacius, MD (1)  ·  Elisabet B Berastegui Garcia, Cardiac surgery (1)  ·  Evelyn Lechner, MD (1)

Results publications

PMID 12947373, PMID 15475828, PMID 16181823, PMID 17086092, PMID 17566702, PMID 18297097, PMID 19700350, PMID 21182783, PMID 21784540, PMID 23620700, PMID 24126568, PMID 24614322, PMID 26082815, PMID 28416392, PMID 29718383, PMID 31315908, PMID 33739957, PMID 33839076, PMID 34716759

NIH funding

2009 (1), 2019 (1)